Clinical Trials on Muskuloskeletal Diseases in Japan

Total 6936 results

Takeda

Completed

Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -

Osseous Paget's Disease

Japan
Atsushi Kawakami
AbbVie GK.

Recruiting

Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate (DOPPLER)

Rheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound

Japan
Okayama University

Unknown

Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block

Arthropathy of Knee Joint

Japan
Pfizer

Completed

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid

Japan
Atsushi Kawakami
Gilead Sciences

Recruiting

Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (TRANSFORM)

Rheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound | IL-6 Inhibitor

Japan
Astellas Pharma Inc
Ono Pharma USA Inc

Completed

A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

Bone Diseases | Osteoporosis | Osteoporosis, Postmenopausal

Japan
Eli Lilly and Company

Completed

A Study of Teriparatide in Japanese Osteoporosis Patients

Osteoporosis

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects

Fibrodysplasia Ossificans Progressiva

Japan
Zimmer Biomet

Completed

Vanguard TKA With KneeAlign 2 and Without KneeAlign 2

Osteoarthritis, Knee

Japan
Osaka City University

Completed

Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis

Femur Head Necrosis

Japan
Yokohama City University Medical Center

Unknown

The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA) (ETOD)

Arthroplasty, Replacement, Hip | Bone Density

Japan
Shinshu University

Recruiting

Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

Osteoporosis

Japan
Shinshu University

Unknown

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

Osteoporosis

Japan
Tomidahama Hospital

Unknown

Effects of Teriparatide Therapy for Japanese

Osteoporosis

Japan
Shinshu University

Recruiting

Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy

Osteoporosis

Japan
Shinshu University

Recruiting

Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

Osteoporosis

Japan
Shinshu University

Completed

Therapeutic Strategy in Postmenopausal Women Using Osteoporotic Diagnostic Kits

Osteoporosis

Japan
Tomidahama Hospital

Unknown

Effects of Denosumab Therapy for Japanese

Osteoporosis

Japan
Tomidahama Hospital

Unknown

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese

Osteoporosis

Japan
Kumamoto University

Completed

Endothelial Dysfunction and Coronary Artery Spasm

Coronary Vasospasm

Japan
Shinshu University

Recruiting

The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis

Osteoporosis

Japan
Takeda

Completed

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

Osteoporosis

Japan
Tomidahama Hospital

Unknown

Age-related Cognitive Change of Femur

Osteoporosis

Japan
e-GLORIA trial Protocol Review Committee

Unknown

Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol (e-GLORIA)

Osteoporosis

Japan
Bayer

Completed

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan (JULINA-CLIMA)

Osteoporosis, Postmenopausal

Japan
Bayer

Completed

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Osteoporosis, Postmenopausal

Japan
Stryker Japan K.K.

Completed

Navigation With X3 vs Non-Navigation With X3 Study

Degenerative Joint Disease

Japan
Pfizer

Completed

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Arthritis, Rheumatoid

Japan
Pfizer

Completed

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid | High Dose

Japan
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
Johnson & Johnson K.K. Medical Company

Completed

Follow-up Study After Bankart Repair Using MG-1

Shoulder Dislocation

Japan
Novo Nordisk A/S

Completed

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

Foetal Growth Problem | Small for Gestational Age

Japan
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia

Japan
Chiba University

Completed

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis (OPTIWIT)

Arthritis, Rheumatoid

Japan
RS Medical
Accelerated Care Plus; Research Institute of Health and Science (RIHSE)

Completed

Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study

Knee Osteoarthritis

Japan
Nihon University

Completed

Comparison of Lingualized and Full Bilaterally Balanced Articulation (denture)

Jaw, Edentulous

Japan
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Japan Biological Agent Study Integrated Consortium

Completed

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (JESMR)

Rheumatoid Arthritis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Sanofi

Completed

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

Knee Osteoarthritis

Japan
Asahi Kasei Pharma Corporation

Completed

A Phase I Study of AK159 in Healthy Postmenopausal Women

Osteoporosis

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

Rheumatoid Arthritis

Japan
Tomidahama Hospital

Unknown

Radiographic Influences of Bisphosphonate Treatment on Femur

Femur Fracture

Japan
Eli Lilly and Company
Shionogi

Completed

An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)

Fibromyalgia

Japan
Shinshu University

Recruiting

Efficacy of Oral Ibandronate in Osteoporosis

Osteoporosis

Japan
Asahi Kasei Pharma Corporation

Completed

Clinical Study of AK159 in Healthy Postmenopausal Women

Osteoporosis

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Daiichi Sankyo, Inc.

Completed

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment (DESIRABLE)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan

3

Subscribe